中鹽化工(600328.SH):擬4.93億元投建氯鹼公司年產6萬噸特種樹脂技術升級改造項目
格隆匯8月14日丨中鹽化工(600328.SH)公佈,公司控股子公司氯鹼公司現有22萬噸/年糊樹脂生產裝置,分別為高分子材料廠9萬噸/年微懸浮糊樹脂裝置和安徽天辰13萬噸/年種子微懸浮糊樹脂裝置。目前氯鹼公司在建3萬噸/年微懸浮糊樹脂裝置,預計2025年12月底建成投產,項目建成後氯鹼公司糊樹脂裝置產能達到25萬噸。為進一步優化公司產業結構,提升公司優勢產品糊樹脂的市場競爭力,公司擬投資建設年產6萬噸特種樹脂技術升級改造項目,本項目總投資為4.93億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.